MARIBAVIR has proved very effective and nontoxic treating Epstein-Barr Infectious Mononucleosis. Medical papers on the subject published on widely circulated medical journals as flws:
1) Journal of Virology - Sept. 2009
Maribavir inhibits Epstein-Barr viral transcription in addition to viral DNA replication
http://jvi.asm.org/cgi/content/abstract/JVI.01575-09v1
Paper published by:
Fu-Zhang Wang, Debasmita Roy, Edward Gershburg, Christopher B. Whitehurst, Dirk P. Dittmer, and Joseph S. Pagano
Departments of Microbiology and Immunology and Medicine, Lineberger Comprehensive Cancer Center, Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, NC; Dept. of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield IL 62794
2) Journal of Antimicrobial Chemotherapy - July 2005
Epstein–Barr virus infections: prospects for treatment
http://jac.oxfordjournals.org/cgi/reprint/56/2/277
Paper published by:
Edward Gershburg and Joseph S. Pagano
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill,
Chapel Hill, NC 27599, USA
3) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2004
Effects of Maribavir and Selected Indolocarbazoles on Epstein-Barr
Virus Protein Kinase BGLF4 and on Viral Lytic Replication
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC400567/pdf/1030-03.pdf
Paper published by:
Edward Gershburg,1 Ke Hong,1 and Joseph S. Pagano1,2,3
Lineberger Comprehensive Cancer Center,1 Department of Microbiology and Immunology,2 and
Department of Medicine,3 University of North Carolina at Chapel Hill,
Chapel Hill, North Carolina 27599
4) ViroPharma statement ref. actual status of MARIBAVIR development.
http://www.viropharma.com/pipeline.aspx
I have to cope with recurrent relapses of EBV.
Does anybody know whether there is a way to get access to this new drug?